Kari Kurppa

9PUBLICATIONS
60CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 24, 2025
Recurrent cancer-associated ERBB4 mutations are transforming and confer resistance to targeted therapies.

Veera K Ojala, Sini Ahonen, Sara Peltola

|Jul 17, 2025
LIMA1-alpha staining predicts curative intent surgery response in HPV negative head and neck cancer.

Xi Qiao, Johannes Routila, Mari Tienhaara

|Jun 17, 2024
DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer.

Majid Momeny, Mari Tienhaara, Mukund Sharma

|Feb 14, 2024
Targeting the mevalonate or Wnt pathways to overcome CAR T-cell resistance in TP53-mutant AML cells.

Jan Mueller, Roman R Schimmer, Christian Koch

Pageof 2